Tracey Lodie
Director/Board Member presso Luminary Therapeutics, Inc.
Profilo
Tracey Lodie is currently a Director at Luminary Therapeutics, Inc. She was previously the Head-Immune Mediated Research Group at Genzyme Corp.
from 2001 to 2015.
From 2015 to 2017, she was the Senior Vice President-Translational Immunology at Bluerock Therapeutics, Inc. In 2019 to 2021, she was the Chief Scientific Officer at Gamida Cell Ltd.
She also worked as the Vice President-Immunology at Syros Pharmaceuticals, Inc. Dr. Lodie received her undergraduate degree from Fairfield University and her doctorate from Boston University School of Medicine.
Posizioni attive di Tracey Lodie
| Società | Posizione | Inizio |
|---|---|---|
Luminary Therapeutics, Inc.
 Luminary Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Luminary Therapeutics, Inc. provides biotechnology services. The company was founded by Jeff Liter, David Largaespada, Beau Webber and Branden Moriarity in 2019 and is headquartered in Minneapolis, MN. | Director/Board Member | - |
Precedenti posizioni note di Tracey Lodie
| Società | Posizione | Fine |
|---|---|---|
| GAMIDA CELL LTD. | Chief Tech/Sci/R&D Officer | 01/07/2021 |
| Bluerock Therapeutics, Inc. | Corporate Officer/Principal | 01/01/2017 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/01/2015 |
| SYROS PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Formazione di Tracey Lodie
| Fairfield University | Undergraduate Degree |
| Boston University School of Medicine | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| GAMIDA CELL LTD. | Health Technology |
| SYROS PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Luminary Therapeutics, Inc.
Luminary Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Luminary Therapeutics, Inc. provides biotechnology services. The company was founded by Jeff Liter, David Largaespada, Beau Webber and Branden Moriarity in 2019 and is headquartered in Minneapolis, MN. | Commercial Services |
| Bluerock Therapeutics, Inc. |
- Borsa valori
- Insiders
- Tracey Lodie
